Global Veterinary Active Pharmaceutical Ingredients (API) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Veterinary Active Pharmaceutical Ingredients (API) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Active Pharmaceutical Ingredients are the substances used in the fabrication of pharmaceutical drugs responsible for beneficial health effects produced by use of the product. An example of an API in veterinary medicine would be trimethoprim-sulfadoxine contained in the products Borgal, Trivetrin, or Trimidox.
This report is a detailed and comprehensive analysis for global Veterinary Active Pharmaceutical Ingredients (API) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Veterinary Active Pharmaceutical Ingredients (API) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Veterinary Active Pharmaceutical Ingredients (API) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Veterinary Active Pharmaceutical Ingredients (API) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Veterinary Active Pharmaceutical Ingredients (API) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Veterinary Active Pharmaceutical Ingredients (API)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Veterinary Active Pharmaceutical Ingredients (API) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alivira Animal Health Ltd, Qilu Pharmaceutical (Inner Mongolia) Co, Ltd, Procyon Life Sciences, SUANFARMAOfichem Group and NGL Fine-Chem Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Veterinary Active Pharmaceutical Ingredients (API) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Veterinary Active Pharmaceutical Ingredients (API) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Veterinary Active Pharmaceutical Ingredients (API), with price, sales, revenue and global market share of Veterinary Active Pharmaceutical Ingredients (API) from 2018 to 2023.
Chapter 3, the Veterinary Active Pharmaceutical Ingredients (API) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Veterinary Active Pharmaceutical Ingredients (API) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Veterinary Active Pharmaceutical Ingredients (API) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Veterinary Active Pharmaceutical Ingredients (API).
Chapter 14 and 15, to describe Veterinary Active Pharmaceutical Ingredients (API) sales channel, distributors, customers, research findings and conclusion.
Active Pharmaceutical Ingredients are the substances used in the fabrication of pharmaceutical drugs responsible for beneficial health effects produced by use of the product. An example of an API in veterinary medicine would be trimethoprim-sulfadoxine contained in the products Borgal, Trivetrin, or Trimidox.
This report is a detailed and comprehensive analysis for global Veterinary Active Pharmaceutical Ingredients (API) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Veterinary Active Pharmaceutical Ingredients (API) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Veterinary Active Pharmaceutical Ingredients (API) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Veterinary Active Pharmaceutical Ingredients (API) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Veterinary Active Pharmaceutical Ingredients (API) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Veterinary Active Pharmaceutical Ingredients (API)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Veterinary Active Pharmaceutical Ingredients (API) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alivira Animal Health Ltd, Qilu Pharmaceutical (Inner Mongolia) Co, Ltd, Procyon Life Sciences, SUANFARMAOfichem Group and NGL Fine-Chem Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Veterinary Active Pharmaceutical Ingredients (API) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Chemical Based API
- Biological API
- Highly Potent APl(HPAPI)
- CDMO
- CMO
- Alivira Animal Health Ltd
- Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
- Procyon Life Sciences
- SUANFARMAOfichem Group
- NGL Fine-Chem Ltd
- Huvepharma
- Jiangsu Lingyun Pharmaceutical Co. Ltd
- Excel Veterinary HealthcareVetpharma(Insud Pharma)
- Menadiona
- lndukern Group
- LasaSupergenerics Ltd.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Veterinary Active Pharmaceutical Ingredients (API) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Veterinary Active Pharmaceutical Ingredients (API), with price, sales, revenue and global market share of Veterinary Active Pharmaceutical Ingredients (API) from 2018 to 2023.
Chapter 3, the Veterinary Active Pharmaceutical Ingredients (API) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Veterinary Active Pharmaceutical Ingredients (API) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Veterinary Active Pharmaceutical Ingredients (API) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Veterinary Active Pharmaceutical Ingredients (API).
Chapter 14 and 15, to describe Veterinary Active Pharmaceutical Ingredients (API) sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Veterinary Active Pharmaceutical Ingredients (API)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Chemical Based API
1.3.3 Biological API
1.3.4 Highly Potent APl(HPAPI)
1.4 Market Analysis by Application
1.4.1 Overview: Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 CDMO
1.4.3 CMO
1.5 Global Veterinary Active Pharmaceutical Ingredients (API) Market Size & Forecast
1.5.1 Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (2018-2029)
1.5.3 Global Veterinary Active Pharmaceutical Ingredients (API) Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Alivira Animal Health Ltd
2.1.1 Alivira Animal Health Ltd Details
2.1.2 Alivira Animal Health Ltd Major Business
2.1.3 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.1.4 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Alivira Animal Health Ltd Recent Developments/Updates
2.2 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
2.2.1 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Details
2.2.2 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Major Business
2.2.3 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.2.4 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Developments/Updates
2.3 Procyon Life Sciences
2.3.1 Procyon Life Sciences Details
2.3.2 Procyon Life Sciences Major Business
2.3.3 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.3.4 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Procyon Life Sciences Recent Developments/Updates
2.4 SUANFARMAOfichem Group
2.4.1 SUANFARMAOfichem Group Details
2.4.2 SUANFARMAOfichem Group Major Business
2.4.3 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.4.4 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 SUANFARMAOfichem Group Recent Developments/Updates
2.5 NGL Fine-Chem Ltd
2.5.1 NGL Fine-Chem Ltd Details
2.5.2 NGL Fine-Chem Ltd Major Business
2.5.3 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.5.4 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 NGL Fine-Chem Ltd Recent Developments/Updates
2.6 Huvepharma
2.6.1 Huvepharma Details
2.6.2 Huvepharma Major Business
2.6.3 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.6.4 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Huvepharma Recent Developments/Updates
2.7 Jiangsu Lingyun Pharmaceutical Co. Ltd
2.7.1 Jiangsu Lingyun Pharmaceutical Co. Ltd Details
2.7.2 Jiangsu Lingyun Pharmaceutical Co. Ltd Major Business
2.7.3 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.7.4 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Developments/Updates
2.8 Excel Veterinary HealthcareVetpharma(Insud Pharma)
2.8.1 Excel Veterinary HealthcareVetpharma(Insud Pharma) Details
2.8.2 Excel Veterinary HealthcareVetpharma(Insud Pharma) Major Business
2.8.3 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.8.4 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Developments/Updates
2.9 Menadiona
2.9.1 Menadiona Details
2.9.2 Menadiona Major Business
2.9.3 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.9.4 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Menadiona Recent Developments/Updates
2.10 lndukern Group
2.10.1 lndukern Group Details
2.10.2 lndukern Group Major Business
2.10.3 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.10.4 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 lndukern Group Recent Developments/Updates
2.11 LasaSupergenerics Ltd.
2.11.1 LasaSupergenerics Ltd. Details
2.11.2 LasaSupergenerics Ltd. Major Business
2.11.3 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.11.4 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 LasaSupergenerics Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS (API) BY MANUFACTURER
3.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Manufacturer (2018-2023)
3.3 Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Veterinary Active Pharmaceutical Ingredients (API) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Veterinary Active Pharmaceutical Ingredients (API) Manufacturer Market Share in 2022
3.4.2 Top 6 Veterinary Active Pharmaceutical Ingredients (API) Manufacturer Market Share in 2022
3.5 Veterinary Active Pharmaceutical Ingredients (API) Market: Overall Company Footprint Analysis
3.5.1 Veterinary Active Pharmaceutical Ingredients (API) Market: Region Footprint
3.5.2 Veterinary Active Pharmaceutical Ingredients (API) Market: Company Product Type Footprint
3.5.3 Veterinary Active Pharmaceutical Ingredients (API) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Veterinary Active Pharmaceutical Ingredients (API) Market Size by Region
4.1.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Region (2018-2029)
4.1.2 Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Region (2018-2029)
4.1.3 Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Region (2018-2029)
4.2 North America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029)
4.3 Europe Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029)
4.4 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029)
4.5 South America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029)
4.6 Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2029)
5.2 Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Type (2018-2029)
5.3 Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2029)
6.2 Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Application (2018-2029)
6.3 Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2029)
7.2 North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2029)
7.3 North America Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country
7.3.1 North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2018-2029)
7.3.2 North America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2029)
8.2 Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2029)
8.3 Europe Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country
8.3.1 Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2018-2029)
8.3.2 Europe Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Market Size by Region
9.3.1 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2029)
10.2 South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2029)
10.3 South America Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country
10.3.1 South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2018-2029)
10.3.2 South America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country
11.3.1 Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Veterinary Active Pharmaceutical Ingredients (API) Market Drivers
12.2 Veterinary Active Pharmaceutical Ingredients (API) Market Restraints
12.3 Veterinary Active Pharmaceutical Ingredients (API) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Veterinary Active Pharmaceutical Ingredients (API) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Veterinary Active Pharmaceutical Ingredients (API)
13.3 Veterinary Active Pharmaceutical Ingredients (API) Production Process
13.4 Veterinary Active Pharmaceutical Ingredients (API) Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Veterinary Active Pharmaceutical Ingredients (API) Typical Distributors
14.3 Veterinary Active Pharmaceutical Ingredients (API) Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Veterinary Active Pharmaceutical Ingredients (API)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Chemical Based API
1.3.3 Biological API
1.3.4 Highly Potent APl(HPAPI)
1.4 Market Analysis by Application
1.4.1 Overview: Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 CDMO
1.4.3 CMO
1.5 Global Veterinary Active Pharmaceutical Ingredients (API) Market Size & Forecast
1.5.1 Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (2018-2029)
1.5.3 Global Veterinary Active Pharmaceutical Ingredients (API) Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Alivira Animal Health Ltd
2.1.1 Alivira Animal Health Ltd Details
2.1.2 Alivira Animal Health Ltd Major Business
2.1.3 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.1.4 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Alivira Animal Health Ltd Recent Developments/Updates
2.2 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
2.2.1 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Details
2.2.2 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Major Business
2.2.3 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.2.4 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Developments/Updates
2.3 Procyon Life Sciences
2.3.1 Procyon Life Sciences Details
2.3.2 Procyon Life Sciences Major Business
2.3.3 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.3.4 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Procyon Life Sciences Recent Developments/Updates
2.4 SUANFARMAOfichem Group
2.4.1 SUANFARMAOfichem Group Details
2.4.2 SUANFARMAOfichem Group Major Business
2.4.3 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.4.4 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 SUANFARMAOfichem Group Recent Developments/Updates
2.5 NGL Fine-Chem Ltd
2.5.1 NGL Fine-Chem Ltd Details
2.5.2 NGL Fine-Chem Ltd Major Business
2.5.3 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.5.4 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 NGL Fine-Chem Ltd Recent Developments/Updates
2.6 Huvepharma
2.6.1 Huvepharma Details
2.6.2 Huvepharma Major Business
2.6.3 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.6.4 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Huvepharma Recent Developments/Updates
2.7 Jiangsu Lingyun Pharmaceutical Co. Ltd
2.7.1 Jiangsu Lingyun Pharmaceutical Co. Ltd Details
2.7.2 Jiangsu Lingyun Pharmaceutical Co. Ltd Major Business
2.7.3 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.7.4 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Developments/Updates
2.8 Excel Veterinary HealthcareVetpharma(Insud Pharma)
2.8.1 Excel Veterinary HealthcareVetpharma(Insud Pharma) Details
2.8.2 Excel Veterinary HealthcareVetpharma(Insud Pharma) Major Business
2.8.3 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.8.4 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Developments/Updates
2.9 Menadiona
2.9.1 Menadiona Details
2.9.2 Menadiona Major Business
2.9.3 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.9.4 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Menadiona Recent Developments/Updates
2.10 lndukern Group
2.10.1 lndukern Group Details
2.10.2 lndukern Group Major Business
2.10.3 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.10.4 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 lndukern Group Recent Developments/Updates
2.11 LasaSupergenerics Ltd.
2.11.1 LasaSupergenerics Ltd. Details
2.11.2 LasaSupergenerics Ltd. Major Business
2.11.3 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Product and Services
2.11.4 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 LasaSupergenerics Ltd. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: VETERINARY ACTIVE PHARMACEUTICAL INGREDIENTS (API) BY MANUFACTURER
3.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Manufacturer (2018-2023)
3.3 Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Veterinary Active Pharmaceutical Ingredients (API) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Veterinary Active Pharmaceutical Ingredients (API) Manufacturer Market Share in 2022
3.4.2 Top 6 Veterinary Active Pharmaceutical Ingredients (API) Manufacturer Market Share in 2022
3.5 Veterinary Active Pharmaceutical Ingredients (API) Market: Overall Company Footprint Analysis
3.5.1 Veterinary Active Pharmaceutical Ingredients (API) Market: Region Footprint
3.5.2 Veterinary Active Pharmaceutical Ingredients (API) Market: Company Product Type Footprint
3.5.3 Veterinary Active Pharmaceutical Ingredients (API) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Veterinary Active Pharmaceutical Ingredients (API) Market Size by Region
4.1.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Region (2018-2029)
4.1.2 Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Region (2018-2029)
4.1.3 Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Region (2018-2029)
4.2 North America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029)
4.3 Europe Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029)
4.4 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029)
4.5 South America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029)
4.6 Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2029)
5.2 Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Type (2018-2029)
5.3 Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2029)
6.2 Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Application (2018-2029)
6.3 Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2029)
7.2 North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2029)
7.3 North America Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country
7.3.1 North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2018-2029)
7.3.2 North America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2029)
8.2 Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2029)
8.3 Europe Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country
8.3.1 Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2018-2029)
8.3.2 Europe Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Market Size by Region
9.3.1 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2029)
10.2 South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2029)
10.3 South America Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country
10.3.1 South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2018-2029)
10.3.2 South America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country
11.3.1 Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Veterinary Active Pharmaceutical Ingredients (API) Market Drivers
12.2 Veterinary Active Pharmaceutical Ingredients (API) Market Restraints
12.3 Veterinary Active Pharmaceutical Ingredients (API) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Veterinary Active Pharmaceutical Ingredients (API) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Veterinary Active Pharmaceutical Ingredients (API)
13.3 Veterinary Active Pharmaceutical Ingredients (API) Production Process
13.4 Veterinary Active Pharmaceutical Ingredients (API) Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Veterinary Active Pharmaceutical Ingredients (API) Typical Distributors
14.3 Veterinary Active Pharmaceutical Ingredients (API) Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Alivira Animal Health Ltd Basic Information, Manufacturing Base and Competitors
Table 4. Alivira Animal Health Ltd Major Business
Table 5. Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 6. Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Alivira Animal Health Ltd Recent Developments/Updates
Table 8. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Basic Information, Manufacturing Base and Competitors
Table 9. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Major Business
Table 10. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 11. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Developments/Updates
Table 13. Procyon Life Sciences Basic Information, Manufacturing Base and Competitors
Table 14. Procyon Life Sciences Major Business
Table 15. Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 16. Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Procyon Life Sciences Recent Developments/Updates
Table 18. SUANFARMAOfichem Group Basic Information, Manufacturing Base and Competitors
Table 19. SUANFARMAOfichem Group Major Business
Table 20. SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 21. SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. SUANFARMAOfichem Group Recent Developments/Updates
Table 23. NGL Fine-Chem Ltd Basic Information, Manufacturing Base and Competitors
Table 24. NGL Fine-Chem Ltd Major Business
Table 25. NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 26. NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. NGL Fine-Chem Ltd Recent Developments/Updates
Table 28. Huvepharma Basic Information, Manufacturing Base and Competitors
Table 29. Huvepharma Major Business
Table 30. Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 31. Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Huvepharma Recent Developments/Updates
Table 33. Jiangsu Lingyun Pharmaceutical Co. Ltd Basic Information, Manufacturing Base and Competitors
Table 34. Jiangsu Lingyun Pharmaceutical Co. Ltd Major Business
Table 35. Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 36. Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Developments/Updates
Table 38. Excel Veterinary HealthcareVetpharma(Insud Pharma) Basic Information, Manufacturing Base and Competitors
Table 39. Excel Veterinary HealthcareVetpharma(Insud Pharma) Major Business
Table 40. Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 41. Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Developments/Updates
Table 43. Menadiona Basic Information, Manufacturing Base and Competitors
Table 44. Menadiona Major Business
Table 45. Menadiona Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 46. Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Menadiona Recent Developments/Updates
Table 48. lndukern Group Basic Information, Manufacturing Base and Competitors
Table 49. lndukern Group Major Business
Table 50. lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 51. lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. lndukern Group Recent Developments/Updates
Table 53. LasaSupergenerics Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. LasaSupergenerics Ltd. Major Business
Table 55. LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 56. LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. LasaSupergenerics Ltd. Recent Developments/Updates
Table 58. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Veterinary Active Pharmaceutical Ingredients (API), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Veterinary Active Pharmaceutical Ingredients (API) Production Site of Key Manufacturer
Table 63. Veterinary Active Pharmaceutical Ingredients (API) Market: Company Product Type Footprint
Table 64. Veterinary Active Pharmaceutical Ingredients (API) Market: Company Product Application Footprint
Table 65. Veterinary Active Pharmaceutical Ingredients (API) New Market Entrants and Barriers to Market Entry
Table 66. Veterinary Active Pharmaceutical Ingredients (API) Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Veterinary Active Pharmaceutical Ingredients (API) Raw Material
Table 126. Key Manufacturers of Veterinary Active Pharmaceutical Ingredients (API) Raw Materials
Table 127. Veterinary Active Pharmaceutical Ingredients (API) Typical Distributors
Table 128. Veterinary Active Pharmaceutical Ingredients (API) Typical Customers
Table 1. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Alivira Animal Health Ltd Basic Information, Manufacturing Base and Competitors
Table 4. Alivira Animal Health Ltd Major Business
Table 5. Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 6. Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Alivira Animal Health Ltd Recent Developments/Updates
Table 8. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Basic Information, Manufacturing Base and Competitors
Table 9. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Major Business
Table 10. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 11. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Developments/Updates
Table 13. Procyon Life Sciences Basic Information, Manufacturing Base and Competitors
Table 14. Procyon Life Sciences Major Business
Table 15. Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 16. Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Procyon Life Sciences Recent Developments/Updates
Table 18. SUANFARMAOfichem Group Basic Information, Manufacturing Base and Competitors
Table 19. SUANFARMAOfichem Group Major Business
Table 20. SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 21. SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. SUANFARMAOfichem Group Recent Developments/Updates
Table 23. NGL Fine-Chem Ltd Basic Information, Manufacturing Base and Competitors
Table 24. NGL Fine-Chem Ltd Major Business
Table 25. NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 26. NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. NGL Fine-Chem Ltd Recent Developments/Updates
Table 28. Huvepharma Basic Information, Manufacturing Base and Competitors
Table 29. Huvepharma Major Business
Table 30. Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 31. Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Huvepharma Recent Developments/Updates
Table 33. Jiangsu Lingyun Pharmaceutical Co. Ltd Basic Information, Manufacturing Base and Competitors
Table 34. Jiangsu Lingyun Pharmaceutical Co. Ltd Major Business
Table 35. Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 36. Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Developments/Updates
Table 38. Excel Veterinary HealthcareVetpharma(Insud Pharma) Basic Information, Manufacturing Base and Competitors
Table 39. Excel Veterinary HealthcareVetpharma(Insud Pharma) Major Business
Table 40. Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 41. Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Developments/Updates
Table 43. Menadiona Basic Information, Manufacturing Base and Competitors
Table 44. Menadiona Major Business
Table 45. Menadiona Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 46. Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Menadiona Recent Developments/Updates
Table 48. lndukern Group Basic Information, Manufacturing Base and Competitors
Table 49. lndukern Group Major Business
Table 50. lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 51. lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. lndukern Group Recent Developments/Updates
Table 53. LasaSupergenerics Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. LasaSupergenerics Ltd. Major Business
Table 55. LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Product and Services
Table 56. LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. LasaSupergenerics Ltd. Recent Developments/Updates
Table 58. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Veterinary Active Pharmaceutical Ingredients (API), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Veterinary Active Pharmaceutical Ingredients (API) Production Site of Key Manufacturer
Table 63. Veterinary Active Pharmaceutical Ingredients (API) Market: Company Product Type Footprint
Table 64. Veterinary Active Pharmaceutical Ingredients (API) Market: Company Product Application Footprint
Table 65. Veterinary Active Pharmaceutical Ingredients (API) New Market Entrants and Barriers to Market Entry
Table 66. Veterinary Active Pharmaceutical Ingredients (API) Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Veterinary Active Pharmaceutical Ingredients (API) Raw Material
Table 126. Key Manufacturers of Veterinary Active Pharmaceutical Ingredients (API) Raw Materials
Table 127. Veterinary Active Pharmaceutical Ingredients (API) Typical Distributors
Table 128. Veterinary Active Pharmaceutical Ingredients (API) Typical Customers
LIST OF FIGURES
Figure 1. Veterinary Active Pharmaceutical Ingredients (API) Picture
Figure 2. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Type in 2022
Figure 4. Chemical Based API Examples
Figure 5. Biological API Examples
Figure 6. Highly Potent APl(HPAPI) Examples
Figure 7. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Application in 2022
Figure 9. CDMO Examples
Figure 10. CMO Examples
Figure 11. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Veterinary Active Pharmaceutical Ingredients (API) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Veterinary Active Pharmaceutical Ingredients (API) Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Veterinary Active Pharmaceutical Ingredients (API) Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Region (2018-2029)
Figure 53. China Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Veterinary Active Pharmaceutical Ingredients (API) Market Drivers
Figure 74. Veterinary Active Pharmaceutical Ingredients (API) Market Restraints
Figure 75. Veterinary Active Pharmaceutical Ingredients (API) Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Veterinary Active Pharmaceutical Ingredients (API) in 2022
Figure 78. Manufacturing Process Analysis of Veterinary Active Pharmaceutical Ingredients (API)
Figure 79. Veterinary Active Pharmaceutical Ingredients (API) Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Veterinary Active Pharmaceutical Ingredients (API) Picture
Figure 2. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Type in 2022
Figure 4. Chemical Based API Examples
Figure 5. Biological API Examples
Figure 6. Highly Potent APl(HPAPI) Examples
Figure 7. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Application in 2022
Figure 9. CDMO Examples
Figure 10. CMO Examples
Figure 11. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Veterinary Active Pharmaceutical Ingredients (API) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Veterinary Active Pharmaceutical Ingredients (API) Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Veterinary Active Pharmaceutical Ingredients (API) Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Region (2018-2029)
Figure 53. China Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Veterinary Active Pharmaceutical Ingredients (API) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Veterinary Active Pharmaceutical Ingredients (API) Market Drivers
Figure 74. Veterinary Active Pharmaceutical Ingredients (API) Market Restraints
Figure 75. Veterinary Active Pharmaceutical Ingredients (API) Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Veterinary Active Pharmaceutical Ingredients (API) in 2022
Figure 78. Manufacturing Process Analysis of Veterinary Active Pharmaceutical Ingredients (API)
Figure 79. Veterinary Active Pharmaceutical Ingredients (API) Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
